搜尋結果
FDA approves Amgen's treatment for most deadly form of lung cancer
CNBC· 5 日前The Food and Drug Administration on Thursday approved Amgen's therapy for patients with the ...
Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer
Bloomberg· 5 日前... won US approval for a new drug to treat a particularly aggressive form of advanced lung &l ...
US FDA approves Amgen drug for small cell lung cancer
Reuters· 5 日前... tab tarlatamab, a targeted immunotherapy for treating adults with advanced small cell lung ...
AstraZeneca aims for $80 bln in total revenue by 2030
Reuters· 5 小時前AstraZeneca, which laid out targets as part of its investor day event, reported total revenue ...
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 1 日前In 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was ...
Council Post: Go Forth, And Fight Aging
Forbes· 7 小時前Recently, he shared a paper in Nature Biotechnology with his hundreds of thousands of Twitter ...
Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial
Reuters· 4 日前, opens new tab $107.5 million in damages, a Delaware federal jury said on Friday after finding ...
Biomed 2024 Showcases Israel’s Resilient Entrepreneurial Spirit
Forbes· 1 日前The need to defend Israeli citizens on multiple fronts for more than seven months has not ...
Lab-Testing Startups Brace for FDA Rule Change
The Wall Street Journal· 5 日前The Food and Drug Administration ruling will increase development costs for lab tests, yet some ...
Med-tech of China gaining popularity
China Daily· 6 日前While taking strides to go global, China's medical technology sector has shown signs of overtaking and leading the world ...